Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

RECENT NEWS

October 23, 2017 Vical Reports Third Quarter 2017 Financial and Operational Results
October 16, 2017 Vical Announces News Release and Conference Call Schedule for Third Quarter 2017 Financial Results

October 23, 2017
Vical Reports Third Quarter 2017 Financial and Operational Results

October 16, 2017
Vical Announces News Release and Conference Call Schedule for Third Quarter 2017 Financial Results

EVENTS & PRESENTATIONS

October 23, 2017 Vical Inc. 3Q17 Financial Results Conference Call View the Webcast
October 18, 2017 Company Update at BIO Investor Forum Conference View the Webcast

October 23, 2017
Vical Inc. 3Q17 Financial Results Conference Call

October 18, 2017
Company Update at BIO Investor Forum Conference

PRODUCT PIPELINE

CONNECT WITH US

RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube

Privacy Policy
Terms of Use
Site Map

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121

This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.